Phase II pilot study of nab-paclitaxel in patients with metastatic or unresectable urothelial cancer previously treated with cisplatin-based chemotherapy.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 May 2016
At a glance
- Drugs Paclitaxel (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 26 Mar 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Oct 2014 New trial record